Theratechnologies inc. has announced the resumption of the distribution of EGRIFTA SVMD following approval from the FDA to release new batches. The product is ready for immediate shipment to pharmacies in their network.

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedarplus.ca and on EDGAR at www.sec.gov.

Theratechnologies inc. resumes distribution of EGRIFTA SVMD to provide treatment for individuals living with HIV.

Product Description

Company Information

Product Launch Insights

Theratechnologies inc. resumes distribution of EGRIFTA SVMD to provide treatment for individuals living with HIV.

Product Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Product Launch Insights

Company Information